OpenEvidence Hits $15B in Back-to-Back Mega Rounds
By @sharedot · · 8 pages
- Startups
- Venture Capital
- Healthcare AI
OpenEvidence raised $250 million at a $15 billion valuation, a $3 billion jump within one year, as hospital systems and Andreessen Horowitz doubled down.
What Happened
OpenEvidence, the Miami-based AI search engine for doctors often called the 'ChatGPT for doctors,' raised $250 million from hospital systems and Andreessen Horowitz, valuing the company at $15 billion, according to people familiar with the matter cited by Business Insider.
The round comes just months after a January financing that valued the company at $12 billion, and Business Insider reports the startup has now raised more than $1 billion in the past year from Thrive Capital, DST, GV, Kleiner Perkins, Sequoia Capital, and Nvidia.
Why the Speed Is Surprising
Back-to-back rounds at rising valuations are rare, but the magnitude here stands out even in a frothy AI market: OpenEvidence was reportedly valued at $6 billion in October, roughly $200 million raised, per PitchBook data cited by Livemint, then $12 billion in January, and now $15 billion — a 150% jump inside twelve months.
That places the clinical AI company among the most valuable private health technology startups, as the lavx.hu report notes, despite unresolved questions about revenue, accuracy, and regulatory risk.
The Evidence: Real Physician Adoption
The valuation rests on unusually deep distribution.
Livemint reports the platform is used daily by more than 40% of U.S. physicians across over 10,000 hospitals and medical centres, supported about 18 million clinical consultations from verified U.S. doctors in December — up from roughly 3 million a month a year earlier — and is free to clinicians in the U.S. and Canada.
Business Insider, citing CNBC, says more than two-thirds of U.S. doctors rely on the product for diagnostic and treatment advice. The company calls itself 'the fastest-growing application for physicians in history.'
The Stakes: AI Giants Circle Healthcare
The round lands as OpenAI, Anthropic, and other AI giants push deeper into healthcare, building their own tools rather than just powering others' products.
Business Insider notes OpenEvidence could be open to selling itself, including access to computing that could grow scarcer if anti-AI sentiment curbs data center expansion, though it may prefer to stay independent.
As an acquisition target, it offers a shortcut: established physician users, experience handling sensitive medical data, and a foothold in a massive market.
A wave of major AI M&A — Nvidia buying Hugging Face for nearly $13 billion and Stripe buying OpenRouter for around $8 billion — shows acquirers are paying up.
The Caveats
The lavx.hu analysis cautions that a $15 billion figure reflects only the price investors accepted in one private round, not a public market price or a guarantee of future revenue, and OpenEvidence has not released enough financial detail to judge the valuation against recurring revenue, retention, or margins.
It also warns that citations do not guarantee safe answers: a model can select a weak study or misread results, and a 2026 Nature Medicine study found benchmark performance between specialized clinical AI and general-purpose models depends heavily on the task and evaluation method.
What Comes Next
Anthropic announced a partnership with OpenEvidence this week, bringing a specialized version of its clinical decision support free to healthcare providers in roughly 100 low- and middle-income countries, including Uganda, Angola, Sudan, Haiti, and Mongolia — with founder Daniel Nadler saying 'access to medical knowledge shouldn't depend on geography,' as Livemint reports.
The company maintains integrations with Google and Microsoft's AI tools and counts Nvidia as an investor. The next test is converting physician habit into durable business results: hospitals paying, clinicians returning, and the system supporting high-stakes work without creating new errors.
Sources
- businessinsider.com › The 'ChatGPT for doctors,' OpenEvidence, was valued at $15 billion in a new funding round
- news.lavx.hu › Investors value OpenEvidence at $15 billion after new $250 million round
- livemint.com › What is OpenEvidence, the 'ChatGPT for doctors' valued at $15 billion in a new funding round?